参考文献/References:
[1] Sun H,Saeedi P,Karuranga S,et al.IDF Diabetes atlas:global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022(183):109119.
[2] Nathan D M,Davidson M B,DeFronzo R A,et al.Impaired fasting glucose and impaired glucose tolerance:implications for care[J].Diabetes Care,2007,30(3):753-759.
[3] 中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志,2021,41(8):668-695.
[4] 中华医学会内分泌学分会,中华医学会糖尿病学分会,中国医师协会内分泌代谢科医师分会,等.中国成人糖尿病前期干预的专家共识(2023版)[J].中华糖尿病杂志,2023,15(6):484-494.
[5] Kawamoto R,Tabara Y,Kohara K,et al.Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults[J].Lipids Health Dis,2010,9:138.
[6] Han T S,Al-Gindan Y Y,Govan L,et al.Associations of BMI,waist circumference,body fat,and skeletal muscle with type 2 diabetes in adults[J].Acta Diabetol,2019(56):947-954.
[7] Kurioka S,Murakami Y,Nishiki M,et al.Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus[J].Endocr J,2002(49):459-464.
[8] Mutie P M,Pomares M H,Atabaki P N,et al.An investigation of causal relationships between prediabetes and vascular complications[J].Nat Commun,2020,11:4592.
[9] Paneni F,Costantino S,Cosentino F.Insulin resistance,diabetes,and cardiovascular risk[J].Curr Atheroscler Rep,2014,16(7):419.
[10] 肖扬,于碧莲.糖尿病患者血脂管理中国专家共识(2024版)[J].中国循环杂志,2024,39(4):322-341.
[11] 李蓉蓉,张永红,李莉,等.内脏脂肪区域、体脂肪率及血脂异常与糖尿病前期的关系[J].实用预防医学,2019,26(2):146-149.
[12] Rajput R,Garg R,Rajput M,et al.Body composition and handgrip strength in patients with prediabetes:a case-control study from Haryana,North India.Diabetes Metab Syndr[J].2021,15(3):823-827.
[13] 贺娟,王颖,尤春娟,等.新诊断2型糖尿病患者体脂肪变化及相关影响因素分析[J].宁夏医学杂志,2024,46(6):519-521.
[14] Fernando G R,Luis E,Manuel G O,et al.The product of triglycerides and glucose,a simple measure of insulin sensitivity comparison with the euglycemic-hyperinsulinemic clamp[J].J Clin Endocrinol Metab,2010,95(7):3347-3351.
[15] Darshan A V,Rajput R,Saini S.Comparison of triglyceride glucose index and HbA1C as a marker of prediabetes-a preliminary study[J].Diabetes Metab Syndr,2022,16(9):102605.
[16] Lee J W,Lim N K,Park H Y.The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans[J].BMC Endocr Disord,2018,18:33.
[17] Zi Q,Wang L M,Zhao S.Triglyceride-glucose index as predictor for future type 2 diabetes mellitus in a Chinese population in southwest China:a 15-year prospective study[J].Endocrine,2021(72):124-131.
[18] Park B,Lee H S,Lee Y J.Triglyceride glucose(TyG)index as a predictor of incident type 2 diabetes among nonobese adults:a 12-year longitudinal study of the Korean genome and epidemiology study cohort[J].Transl Res,2021(228):42-51.
[19] Wen J,Wang A,Liu G,et al.Elevated triglyceride-glucose(TyG)index predicts incidence of prediabetes:a prospective cohort study in China[J].Lipids Health Dis,2020,19(1):226.
[20] Zhou Y M,Yang G P,Chen Q,et al.Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes:a cross-sectional study in eastern China[J].BMC Endocr Disord,2022,22:76.
[21] Kumpatla S,Parveen R,Murugan P,et al.Hyperglucagone-mia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - a study from South India[J].Diabetes Metab Syndr,2021,15(4):102199.
[22] Zhang L H,Zeng L.Non-linear association of triglyceride-glucose index with prevalence of prediabetes and diabetes:a cross-sectional study[J].Front Endocrinol(Lausanne),2023,14:1-10.
[23] 吴延莉,苏旭,王艺颖,等.LDL-C/HDL-C比值与2型糖尿病发病关系的队列研究[J].现代预防医学,2023,50(12):2252-2258.
[24] 余国庆,孙红,李君,等.2型糖尿病患者TyG指数、LDL-C/HDL-C比值与糖化血红蛋白的相关性研究[J].糖尿病新世界,2023,26(9):18-22.
[25] 计叶,徐文超.血脂参数及脂质比值与糖代谢异常的关联研究[J].现代预防医学,2024,51(14):2628-2633.
[26] 中华医学会内分泌学分会,中华中医药学会糖尿病分会,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会,中国研究型医院学会糖尿病与肥胖外科专业委员会.基于临床的肥胖症多学科诊疗共识(2021年版)[J].中华消化外科杂志,2021,20(11):1137-1152.
[27] 中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识 [J].中华糖尿病杂志,2016,8(11):662-666.
[28] 刘惠双.腹腔内脏脂肪面积与慢性疾病相关性研究[J].中国现代药物应用,2016,10(2):88-89.
[29] Rubio-Almanza M,Cámara-Gómez R,Merino-Torres J F.Obesity and type 2 diabetes:also linked in therapeutic options[J].Endocrinol Diabetes Nutr(Engl Ed),2019,66(3):140-149.
[30] 卢新妍,林萱,崔静,等.甘油三酯-葡萄糖指数与内脏脂肪面积联合检测对2型糖尿病早期外周血管病变的预测价值[J].武汉大学学报:医学版,2024,45(5):582-588.
相似文献/References:
[1]李 敏 姜 锋 魏潇琪 王小易 林燕清 郑炜平.Kisspeptin对胰岛β细胞的凋亡影响及作用机制研究[J].福建医药杂志,2020,42(01):125.
LI Min,JIANG Feng,WEI Xiaoqi,et al.Study on the effect and mechanism of kisspeptin on apoptosis of islet β cells[J].FUJIAN MEDICAL JOURNAL,2020,42(03):125.
[2]林燕玲,叶静,黄淑玲,等.血清VEGF、BDNF水平与老年糖尿病大鼠认知功能障碍相关性研究[J].福建医药杂志,2022,44(02):123.
LIN Yanling,YE Jing,HUANG Shuling,et al.The correlation between serum levels of VEGF and BDNF and cognitive dysfunction in elderly diabetic rats[J].FUJIAN MEDICAL JOURNAL,2022,44(03):123.
[3]陈端英,何孙本,黄旭日,等.MicroRNA-16-5p和血管内皮生长因子与糖尿病微血管病变的相关性研究[J].福建医药杂志,2024,46(03):9.[doi:10.20148/j.fmj.2024.03.003]
CHEN Duanying,HE Sunben,HUANG Xuri,et al.Correlation between expression of serum MicroRNA-16-5p and vascular endothelial growth factor and diabetic microangiopathy[J].FUJIAN MEDICAL JOURNAL,2024,46(03):9.[doi:10.20148/j.fmj.2024.03.003]